ICON Public (NASDAQ:ICLR) Earns Equal Weight Rating from Barclays

Barclays reaffirmed their equal weight rating on shares of ICON Public (NASDAQ:ICLR – Free Report) in a research report report published on Thursday, Marketbeat.com reports. Barclays currently has a $165.00 price target on the medical research company’s stock, down from their previous price target of $240.00. Other equities analysts have also recently issued reports about […]